Research on Smartwatch App for Atrial Fibrillation Detection
Introduction to the Study
Researchers from Stanford University aimed to determine if a smartwatch app could effectively detect atrial fibrillation in individuals with no previous history of the condition. As smartphone applications become integral to managing everyday activities, the potential for health monitoring through technology raises important questions about their effectiveness.
Atrial Fibrillation and Its Risks
Atrial fibrillation (AFib), characterized by an irregular heart rhythm, impacts approximately six million Americans. If undiagnosed, AFib can significantly increase the risk of heart failure and stroke. Traditional heart monitors typically provide limited monitoring periods, often resulting in missed fibrillations. Some patients may even need to undergo procedures to implant monitoring devices, which can further complicate early detection.
Advantages of Smartwatch Monitoring
Smartwatches offer a distinct advantage, as they can be worn continuously and unobtrusively. Leveraging this benefit, the research team conducted a comprehensive online trial to evaluate the effectiveness of the smartwatch app in detecting atrial fibrillation.
Study Parameters and Participation
The app was made available in the United States from November 29, 2017, to August 1, 2018. During this period, 419,297 participants were recruited, and 2,161 received notifications indicating an irregular heart rhythm. Those notified were subsequently sent an electrocardiogram (ECG) patch to verify the smartwatch app notifications.
Key Findings of the Study
The study revealed two significant findings for participants who received notifications:
1. The ECG patch indicated that 34% of participants had atrial fibrillation.
2. When participants wore the ECG patch, 84% of the notifications from the app were confirmed as atrial fibrillation.
The first finding is clinically relevant as it demonstrated that the ECG detected longer and more uncomfortable fibrillation episodes, some lasting over an hour. Even in cases where the ECG did not show AFib, the infrequency of fibrillations could mean they were not present during the monitoring period.
The second finding highlights the app’s low incidence of false notifications, suggesting that when participants received an alert, it was likely due to actual atrial fibrillation rather than a glitch in the app. However, the study did indicate that short episodes of AFib might go undetected.
Challenges and Implications of the Study
Despite the study’s accessibility and being conducted entirely online, a limited number of ECG patches were returned for analysis. Nonetheless, the research illustrates how digital health can transform both research methodologies and healthcare delivery. The app facilitated public participation in a clinical trial without the barriers of travel or significant costs.
Additionally, 76% of participants who received notifications sought medical consultation, whether through telemedicine or other healthcare providers. The study suggests that advancements in technology could enhance patient engagement with healthcare systems, making it easier for individuals to connect with medical professionals.
References
– Perez, M., Mahaffey, K., Hedlin, H., Rumsfeld, J., Garcia, A., Ferris, T., Balasubramanian, V., Russo, A., Rajmane, A., Cheung, L., Hung, G., Lee, J., Kowey, P., Talati, N., Nag, D., Gummidipundi, S., Beatty, A., Hills, M., Desai, S., Granger, C., Desai, M. and Turakhia, M. (2019). Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. New England Journal of Medicine, 381(20), pp.1909-1917.
– heart.org. (2019). What is Atrial Fibrillation (AFib or AF)?. [online] Available at: https://www.heart.org/en/health-topics/atrial-fibrillation/what-is-atrial-fibrillation-afib-or-af [Accessed 20 Nov. 2019].
– Heart and Stroke Foundation of Canada. (2019). Electrocardiogram. [online] Available at: https://www.heartandstroke.ca/heart/tests/electrocardiogram [Accessed 20 Nov. 2019].